tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Shanghai Henlius Biotech Gains EU Approval for Osteoporosis Treatments
PremiumCompany AnnouncementsShanghai Henlius Biotech Gains EU Approval for Osteoporosis Treatments
1M ago
Shanghai Henlius Biotech Advances HLX43 Clinical Trials for Lung Cancer
Premium
Company Announcements
Shanghai Henlius Biotech Advances HLX43 Clinical Trials for Lung Cancer
1M ago
Shanghai Henlius Biotech’s HLX17 Receives FDA Approval for Clinical Trials
Premium
Company Announcements
Shanghai Henlius Biotech’s HLX17 Receives FDA Approval for Clinical Trials
2M ago
Shanghai Henlius Biotech: Strong Financial Performance and Promising Product Pipeline Drive Buy Rating
PremiumRatingsShanghai Henlius Biotech: Strong Financial Performance and Promising Product Pipeline Drive Buy Rating
2M ago
Shanghai Henlius Biotech Reports Growth and Expands Global Reach in 2025
Premium
Company Announcements
Shanghai Henlius Biotech Reports Growth and Expands Global Reach in 2025
2M ago
Shanghai Henlius Biotech Advances HLX43 Clinical Trials in the US
Premium
Company Announcements
Shanghai Henlius Biotech Advances HLX43 Clinical Trials in the US
2M ago
Shanghai Henlius Biotech Gains FDA Approval for HLX43 Clinical Trial
PremiumCompany AnnouncementsShanghai Henlius Biotech Gains FDA Approval for HLX43 Clinical Trial
3M ago
Shanghai Henlius Initiates Phase 2 Study for HLX79 in Glomerulonephritis Treatment
Premium
Company Announcements
Shanghai Henlius Initiates Phase 2 Study for HLX79 in Glomerulonephritis Treatment
3M ago
Shanghai Henlius Biotech Schedules Board Meeting to Discuss Interim Results and Dividend
Premium
Company Announcements
Shanghai Henlius Biotech Schedules Board Meeting to Discuss Interim Results and Dividend
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100